Genprex, Inc.
GNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,441 | $6,291 | $3,743 | $9,249 |
| - Cash | $1,103 | $1,347 | $3,468 | $1,602 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5,338 | $4,945 | $275 | $7,647 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,799 | -$4,682 | -$3,968 | -$4,330 |
| % Margin | – | – | – | – |
| Net Income | -$3,799 | -$4,675 | -$3,965 | -$4,330 |
| % Margin | – | – | – | – |
| EPS Diluted | -5 | -8.5 | -13 | -21 |
| % Growth | 41.2% | 34.6% | 38.1% | – |
| Operating Cash Flow | -$3,187 | -$3,864 | -$4,161 | -$3,869 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$17 |
| Free Cash Flow | -$3,187 | -$3,864 | -$4,161 | -$3,869 |